Stephane Chatonsky
Chairman & Investor @ Prospection
Sydney, Australia
Stephane Chatonsky is a seed investor at Prospection in Sydney focused on Big Data and Analytics. Stephane Chatonsky is the Chairman of & an Investor in Prospection.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Stephane Chatonsky invests in
Stages Stephane Chatonsky invests in
Countries Stephane Chatonsky invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Big Data 1 (33%)
- Analytics 1 (33%)
- Wholesale 1 (33%)
- Consulting 1 (33%)
- Health Care 1 (33%)
Stage
- Seed 1 (33%)
- Pre-Seed 1 (33%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Thinxtra, The IoT Telco
|
Thinxtra is an Internet of Things (IoT) company founded by IoT experts who share the same passion and expertise: connecting things to improve business processes. | $7.9M / Series B / Aug 18, 2017 | |
Prospection
|
Prospection is a Pioneer in healthcare data analytics. Using predictive analytics and machine learning with real world healthcare data to unearth insights that help research, develop and target better healthcare outcomes for patients. Founded out of Sydney’s Cicada Innovations in 2012, Prospection works with government, pharmaceutical companies andthe medical community across more than 90 therapy programs, including immuno-oncology, Diabetes, Respiratory, HIV and hepatitis, in Australia, Japan, Asia Pacific, UK and USA. | Seed | |
eBev.com
|
eBev connects hospitality beverage buyers with all of the beverage suppliers in their market. Members can buy, sell, compare, shortlist, order, transact, manage inventory, analyze performance and communicate on eBev. All your beverage needs are now available on one easy to use modern platform. | Pre-Seed |
Co-Investors
About Prospection
Prospection is a Pioneer in healthcare data analytics. Using predictive analytics and machine learning with real world healthcare data to unearth insights that help research, develop and target better healthcare outcomes for patients. Founded out of Sydney’s Cicada Innovations in 2012, Prospection works with government, pharmaceutical companies andthe medical community across more than 90 therapy programs, including immuno-oncology, Diabetes, Respiratory, HIV and hepatitis, in Australia, Japan, Asia Pacific, UK and USA.
Prospection Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adam Hawkins
Director International Business
|
|||
Eric Chung
Chief Executive Officer, Co-Founder
|
|||
Greg Hughes
Director of ANZ
|
|||
Kirsten Mann
Chief Product Officer
|
|||
Peter Cronin
Director of Strategic Partnerships and Data, Co-Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Stephane Chatonsky invest in?
Stephane Chatonsky invests primarily in Big Data, Analytics and Wholesale startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Stephane Chatonsky?
Public channels for Stephane Chatonsky include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Stephane Chatonsky last invest?
The most recent investment recorded for Stephane Chatonsky closed in Aug 2017. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
